The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention
Clinical trial NCT03331484 · COMPLETED
Trial details
- NCT number
- NCT03331484
- Sponsor
- Ottawa Heart Institute Research Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-01
- Primary completion
- 2023-07-06
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.